Compare ADMA Biologics Inc (ADMA) vs Docusign Inc (DOCU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Docusign Inc — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Docusign Inc trades at $58.39 (market cap $11.33B). The key difference: Docusign Inc is far larger — about 5.1× ADMA Biologics Inc's market cap, and Docusign Inc is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.
| ADMA | DOCU | |
|---|---|---|
Market Cap | $2.22B | $11.33B |
Sector | Health | Technology |
52-Week High | $20.38 | $85.01 |
52-Week Low | $7.60 | $41.75 |
Enterprise Value | $2.29B | $10.70B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Docusign Inc
DocuSign offers the Agreement Cloud, a broad cloud-based software suite that enables users to automate the agreement process and provide legally binding e-signatures from nearly any device. The company was founded in 2003 and completed its IPO in May 2018.
Read more on DOCU →
